Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...
Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts. Pharmaceutical...
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
Methods for Studying Drug Absorption: In vitro01:16

Methods for Studying Drug Absorption: In vitro

In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Easy, Flexible and Standardizable Anti-Nascent Biofilm Activity Assay to Assess Implant Materials.

Microorganisms·2023
Same author

A Novel Bioreactor System Capable of Simulating the <i>In Vivo</i> Conditions of Synovial Joints.

Tissue engineering. Part C, Methods·2020
Same author

Controlled formation of chitosan particles by a clock reaction.

Soft matter·2018
Same author

In vitro methods for the evaluation of antimicrobial surface designs.

Acta biomaterialia·2018
Same author

Absorbable mineral nanocomposite for biomedical applications: Influence of homogenous fiber dispersity on mechanical properties.

Journal of biomedical materials research. Part A·2017
Same author

Harvesting pre-polarized macrophages using thermo-responsive substrates.

Scientific reports·2017

Related Experiment Video

Updated: May 28, 2026

Accessing the Cytotoxicity and Cell Response to Biomaterials
09:46

Accessing the Cytotoxicity and Cell Response to Biomaterials

Published on: July 8, 2021

Evaluation of biocompatibility using in vitro methods: interpretation and limitations.

Arie Bruinink1, Reto Luginbuehl

  • 1Laboratory for Materials - Biology Interactions, Empa - Materials Science and Technology, Lerchenfeldstasse 5, CH-9014 St, Gallen, Switzerland, Arie.Bruinink@empa.ch.

Advances in Biochemical Engineering/Biotechnology
|October 13, 2011
PubMed
Summary

Proving in vitro biocompatibility is crucial for new medical device materials using cell culture tests. This study critically examines the limitations of ISO 10993-5 in vitro testing and explores alternative strategies.

More Related Videos

The Use of the Ex Vivo Chandler Loop Apparatus to Assess the Biocompatibility of Modified Polymeric Blood Conduits
10:15

The Use of the Ex Vivo Chandler Loop Apparatus to Assess the Biocompatibility of Modified Polymeric Blood Conduits

Published on: August 20, 2014

Direct and Indirect Culture Methods for Studying Biodegradable Implant Materials In Vitro
14:49

Direct and Indirect Culture Methods for Studying Biodegradable Implant Materials In Vitro

Published on: April 15, 2022

Related Experiment Videos

Last Updated: May 28, 2026

Accessing the Cytotoxicity and Cell Response to Biomaterials
09:46

Accessing the Cytotoxicity and Cell Response to Biomaterials

Published on: July 8, 2021

The Use of the Ex Vivo Chandler Loop Apparatus to Assess the Biocompatibility of Modified Polymeric Blood Conduits
10:15

The Use of the Ex Vivo Chandler Loop Apparatus to Assess the Biocompatibility of Modified Polymeric Blood Conduits

Published on: August 20, 2014

Direct and Indirect Culture Methods for Studying Biodegradable Implant Materials In Vitro
14:49

Direct and Indirect Culture Methods for Studying Biodegradable Implant Materials In Vitro

Published on: April 15, 2022

Area of Science:

  • Biomaterials Science
  • Toxicology
  • Medical Device Development

Background:

  • In vitro biocompatibility testing is a mandatory first step for novel medical device materials.
  • Standardized cell culture tests, such as ISO 10993-5, are currently employed.
  • Preclinical and clinical evaluations are required subsequent to in vitro assessments.

Purpose of the Study:

  • To critically evaluate the significance and limitations of in vitro biocompatibility testing according to ISO 10993-5.
  • To explore alternative strategies for assessing the in vitro biocompatibility of medical device materials.
  • To provide an overview of ongoing efforts to enhance current in vitro testing methodologies.

Main Methods:

  • Focus on the in vitro testing phase as defined by ISO 10993-5.
  • Critical discussion of the methodologies and outcomes of standard in vitro biocompatibility tests.
  • Review of alternative in vitro approaches and research initiatives.

Main Results:

  • The current in vitro testing according to ISO 10993-5 has limited predictive significance for in vivo performance.
  • Existing standardized tests may not fully capture the complex biological interactions of materials.
  • There is a recognized need for improved and alternative in vitro methods.

Conclusions:

  • In vitro biocompatibility testing is essential but has inherent limitations.
  • ISO 10993-5 testing alone is insufficient for comprehensive material safety assessment.
  • Advancements in alternative in vitro strategies are necessary to improve the reliability of early-stage material evaluation for medical devices.